| Literature DB >> 35689694 |
Christoph Wipplinger1,2, Sara Lener1, Christoph Orban1, Tamara M Wipplinger2,3, Anto Abramovic1, Anna Lang1, Sebastian Hartmann1, Claudius Thomé4.
Abstract
PURPOSE: Approaches for lumbar corpectomies can be roughly categorized into anterolateral (AL) and posterolateral (PL) approaches. It remains controversial to date whether one approach is superior to the other, and no comparative studies exist for the two approaches for lumbar corpectomies.Entities:
Keywords: Anterolateral lumbar corpectomy; Lumbar corpectomy; Posterolateral lumbar corpectomy; Vertebral body resection
Mesh:
Year: 2022 PMID: 35689694 PMCID: PMC9338118 DOI: 10.1007/s00701-022-05240-8
Source DB: PubMed Journal: Acta Neurochir (Wien) ISSN: 0001-6268 Impact factor: 2.816
Fig. 1Screening algorithm
Overview of included studies; y yes, n no, AL anterolateral, PL posterolateral, I infection, T trauma, D degenerative and deformity, N neoplasia, O osteoporosis, VBR vertebral body replacement, SC static cage, EC expandable cage, AB autologous bone only, BC bone cement, N/A not available, EBL estimated blood loss, ST surgical time, NI neurological improvement, ND neurological deterioration, NU neurologically unchanged
| Author | Year | Level of evidence | Lumbar only | Number of patients | Approach | Pathology | VBR | Instrumentation approach | Fused vertebrae | EBL | ST | Complications | Revsion surgeries | NI | ND | NU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alhashash et al. [ | 2021 | IV | n | 33 | AL | D, O | EC | Additional | 3 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Alshareef et al. [ | 2020 | IV | n | 9 | PL | N | EC | Same | 4 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Aryan et al. [ | 2007 | IV | n | 4 | AL | I | SC, EC | Additional | N/A | N/A | N/A | 1 | 0 | N/A | N/A | N/A |
| Bhat et al. [ | 1999 | IV | n | 7 | AL | T (5), I (2) | SC | Same | 3 | N/A | N/A | N/A | N/A | 2 | 0 | 5 |
| Byvaltsev et al. [ | 2021 | IV | n | 16 | AL | T | EC | Additional | 3 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cho [ | 2017 | IV | n | 3 | PL | D | SC | Same | 5 | 550 | 201 | N/A | N/A | 2 | 0 | 1 |
| Choi et al. [ | 2017 | IV | n | 11 | PL | T | EC | Same | 3 | 1007 | 208.8 | 2 | 0 | 8 | 0 | 3 |
| Chou et Lu [ | 2011 | III | n | 3 | PL | T (2), I (1) | EC | Same | N/A | 1067 | 560 | 2 | 1 | 0 | 0 | 3 |
| Dai [ | 2010 | IV | y | 15 | AL | N (6), I (9) | EC, AB | Same | N/A | N/A | N/A | 1 | 0 | 9 | 0 | 6 |
| Dvorak et al. [ | 2003 | IV | n | 30 | AL | D (4), N (2), T (25), I (1) | EC | N/A | 3 | N/A | N/A | 1 | 1 | N/A | N/A | N/A |
| Elnady et al. [ | 2017 | IV | y | 17 | PL | N (9), T (3), I (5) | SC, EC | Same | 5 | 744 | 186.1 | 2 | 1 | N/A | N/A | N/A |
| Gezercan et al. [ | 2016 | IV | n | 7 | PL | N | EC | Same | 5 | N/A | N/A | N/A | N/A | 4 | 0 | 3 |
| Grobost et al. [ | 2020 | IV | n | 33 | AL | T | EC | Additional | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Hofstetter et al. [ | 2011 | IV | n | 17 | PL | T | EC | Same | 3 | 1150 | 324 | 3 | 3 | N/A | N/A | N/A |
| Jandial et al. [ | 2013 | IV | y | 11 | PL | N | EC | Same | 5 | 1618 | 393 | 5 | 2 | 6 | 0 | 5 |
| Joubert et al. [ | 2015 | IV | n | 4 | PL | N | EC | Same | 5 | 862 | 164 | N/A | N/A | N/A | 0 | N/A |
| Knoeller et al. [ | 2012 | IV | y | 45 | AL | N | EC | Same | N/A | N/A | N/A | 7 | 0 | 19 | 0 | 26 |
| Koller et al. [ | 2021 | IV | y | 17 | AL | D | EC | Additional | N/A | N/A | N/A | 16 | N/A | 0 | 10 | 7 |
| Korovessis et al. [ | 2008 | IV | n | 23 | AL | I | SC | Additional | 4 | 860 | 270 | 1 | 1 | 9 | 0 | 14 |
| Liljenqvist et al. [ | 2003 | IV | n | 13 | AL | I | SC | Additional | 5 | 1965 | 340 | 1 | 0 | 1 | 2 | 10 |
| Lu et al. [ | 2010 | III | n | 27 | AL (24), PL (3) | N (8), T (12),I (7) | SC,EC,AB, BC | Both | 3 | N/A | N/A | 10 | 0 | 8 | 2 | 17 |
| Lu et al. [ | 2009 | III | n | 12 | AL (10), PL (2) | I | SC,EC,AB | Both | N/A | N/A | N/A | 1 | 1 | 8 | 0 | 4 |
| Mallepally et al. [ | 2021 | IV | y | 45 | PL | T | SC | Same | 4 | 1280 | 220 | 8 | 1 | 15 | 0 | 30 |
| Mühlbauer et al. [ | 2000 | IV | y | 5 | AL | O (4), N (1) | SC | Both | 3 | 1120 | 360 | 1 | 0 | 5 | 0 | 0 |
| Nakashima et al. [ | 2021 | IV | n | 25 | AL | O | SC,EC | Additional | 3 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Payer et Sottas [ | 2008 | IV | n | 26 | AL | N (5), T (21) | EC | Additional | 3 | 670 | 191 | 3 | 0 | N/A | N/A | N/A |
| Pham et al. [ | 2017 | IV | y | 7 | PL | T | EC | Same | 5 | N/A | N/A | 10 | 2 | 2 | 0 | 5 |
| Richardson et al. [ | 2017 | IV | y | 42 | AL | T | EC | Same | 3 | N/A | N/A | 1 | 0 | N/A | N/A | N/A |
| Sasani et Özir [ | 2009 | IV | n | 9 | PL | T | EC | Same | 3 | 467 | 182.2 | N/A | N/A | 3 | 0 | 6 |
| Scheufler [ | 2007 | IV | n | 10 | AL | N (7), T (1), I (2) | EC | Additional | N/A | 420 | 175 | 6 | 1 | 5 | 0 | 4 |
| Senel et al. [ | 2007 | IV | n | 3 | PL | N | BC | Same | 3 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shen et al. [ | 2008 | IV | n | 8 | PL | N | EC | Same | 4 | 1350 | 318 | 3 | 1 | N/A | N/A | N/A |
| Shousha et al. [ | 2014 | IV | y | 25 | AL | O (3), N (11), T (8), I (3) | EC | Both | 3 | 3230 | 158 | 2 | 0 | 12 | 0 | 13 |
| Singh et al. [ | 2012 | IV | y | 15 | PL | N (12), I (3) | EC | Same | 5 | 2400 | N/A | N/A | N/A | 3 | 0 | 12 |
| Smith et al. [ | 2010 | IV | n | 34 | AL | T | EC | Both | N/A | 300 | 128 | N/A | N/A | N/A | N/A | N/A |
| Street et al. [ | 2007 | II | n | 8 | PL | N | BC | Same | N/A | N/A | N/A | 5 | 3 | N/A | N/A | N/A |
| Theologis et al. [ | 2016 | IV | y | 12 | AL | T | EC | Additional | N/A | 988 | 288.7 | 2 | 2 | 4 | 0 | 8 |
| Vazan et al. [ | 2017 | IV | y | 14 | AL | D(2), N(3), T(2), I(7) | SC, EC | Additional | 4 | N/A | 186.9 | 4 | 3 | N/A | N/A | N/A |
| Wong et al. [ | 2014 | IV | n | 1 | PL | N | EC | Same | 4 | 1000 | 360 | N/A | N/A | N/A | N/A | N/A |
| Zidan et al. [ | 2019 | IV | y | 30 | AL | O (4), N (8), T (12), I (6) | SC, EC, AB, BC | Additional | 5 | 600 | 220 | 13 | 2 | 19 | 1 | 10 |
Indications for corpectomy
| Anterolateral | Posterolateral | |||
|---|---|---|---|---|
| % | % | |||
| Trauma | 223 | 58.53% | 99 | 52.38% |
| Neoplasia | 107 | 28.08% | 74 | 39.15% |
| Infection | 86 | 22.57% | 12 | 6.35% |
| Osteoporosis | 70 | 18.37% | 1 | 0.53% |
| Degeneration and deformity | 27 | 7.09% | 3 | 1.59% |
| Total | ||||
Approach-related complications reported in 34 articles including 499 patients, p-values < 0.05 were considered statistically significant
| Anterolateral ( | Posterolateral ( | |||
|---|---|---|---|---|
| Wound infection/dehiscence | 3.99% | 14 | 2.70% | 4 |
| Durotomy | 1.42% | 5 | 10.14% | 15 |
| Pulmonary complications | 2.28% | 8 | 0.00% | 0 |
| Vascular injury | 2.28% | 8 | 0.00% | 0 |
| Post-OP hemorrhage | 0.00% | 0 | 2.70% | 4 |
| Implant-related | 3.70% | 13 | 8.11% | 12 |
| Organ/peritoneal injury | 1.71% | 6 | 0.00% | 0 |
| Nerve damage | 3.42% | 12 | 2.70% | 4 |
| Adjacent segment disease | 1.71% | 6 | 2.70% | 4 |
| Overall complication rate | ||||
Fig. 2Approach-related complication rates in anterolateral (AL) and posterolateral (PL) corpectomies
Fig. 3Revision surgeries due to complications from anterolateral (AL) and posterolateral (PL) corpectomies
Fig. 4Neurological outcomes of anterolateral (AL) and posterolateral (PL) corpectomies